Steven H. Holtzman, President and CEO at INFINITY PHARMACEUTICALS, INC. (INFI), bought 22,103 shares at $7.40 ($164K) on 2008-08-27, disclosed to the SEC on 2008-08-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| BIIB | SELL | 2014-11-12 | $578K | — | Filing → |
| BIIB | SELL | 2014-10-02 | $579K | — | Filing → |
| BIIB | SELL | 2014-05-20 | $353K | — | Filing → |